Pharmaceutical industry – Page 7
-
BusinessSecond Alzheimer’s antibody approved in the US
Biogen–Eisai’s lecanemab can slow disease progression a little, but at significant cost and risk of side effects
-
OpinionSetting drug development speed records
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
-
BusinessUK antibiotics supply chain stretched by surge in Strep A infections
Government enacts protocols to enable substitute treatments and recommends preventive prescriptions in severe cases
-
BusinessPharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
-
BusinessJudge dismisses ranitidine lawsuits over lack of evidence
Drug degrades to produce nitrosamines, but the judge ruled the link between this and plaintiffs’ cancers could not be proven
-
BusinessTheranos leaders to be imprisoned for blood testing fraud
Sunny Balwani and Elizabeth Holmes will both serve more than 10 years
-
BusinessUS government intervenes to avert rail strike
Congress enforces a contract deal to prevent a national rail shutdown that would effectively halt chemicals production
-
ArticleTime waits for no scientist: Five ways to enhance lab productivity and stay ahead of the competition in 2023
Manage your resources effectively to maximise your lab’s core activity: science
-
OpinionEmbracing oddities
When new chemistry looks like alchemy or witchcraft, it’s worth taking notice
-
ArticleThermal analysis in the development of long-acting injectable systems
Evaluating new polymers for slow-release drug delivery could deliver better treatment for patients
-
OpinionWhat to expect when your customer’s quality auditor visits
Checking a chemical plant is meeting standards
-
WebinarAnalytical impurity standards – minimise project risk & avoid common pitfalls
Learn how to save time and money by understanding what’s at stake when working with analytical impurity standards.
-
BusinessEurope gears up for streamlined patent system
Delayed Unified Patent Court set to begin operating in April
-
BusinessUK firms face critical lab space shortage
Growing chemistry companies hit a wall when it comes to expanding their labs
-
ArticleInspiring a new era of patient-centric medicines
Christian Jones discusses new formulations for drug delivery that put people first
-
ArticleNew frontiers in synthesis for a more sustainable future
AstraZeneca’s collaborations with academia are essential to harnessing the latest technology in the pursuit of new and sustainable medicines
-
BusinessContaminated cough syrup linked to 66 child deaths in The Gambia
Medicines made by Indian generics firm Maiden Pharmaceuticals have been blamed for acute kidney injuries
-
FeatureTiny delivery systems for cancer drugs
Encapsulating anticancer agents in nanoparticles can make them gentler on the rest of the body. Clare Sansom reports
-
OpinionNobel vision
Looking beyond the here-and-now let click chemistry open up a whole new world of possibility
-
BusinessAlzheimer’s antibody engenders anticipation
Tantalising press-released data on Biogen and Eisai’s lecanemab prompt questions without firm answers